Renography before heart transplantation in patients with cardiomyopathy

被引:0
|
作者
Aigner, RM
O'Mara, RE
Fueger, GF
Tscheliessnigg, K
Nicoletti, R
Sorantin, E
Smith, EM
机构
[1] Univ Rochester Hosp, Dept Radiol, Div Nucl Med, Graz, Austria
[2] Univ Rochester Hosp, Dept Surg, Div Transplant Surg, Graz, Austria
关键词
ischemic cardiomyopathy; heart transplantation; dynamic renal scintigraphy; prognosis; renal dysfunction;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In patients with ischemic cardiomyopathy (CM), abnormal renograms may result not only from circulatory failure (which should reverse after transplantation) but also from intrinsic renal disease (which contraindicates heart transplantation). Here, the outcome of heart transplantation was related to preoperative renograms, and the differentiating and prognostic value of renography was analyzed. Methods: The study population consisted of 50 patients with ischemic CM expecting heart transplantation. Anatomical renal pathology was excluded in all patients. Dynamic renal scintigraphy was performed with (99m)Tc-mercaptoacetyltriglycine. Background-subtracted renograms were inspected visually and characterized numerically. Mean parenchymal transit time (mPTT), renal tracer content at 15 min (RTC15) and retention index (RI) were determined. The parametric renogram values were related to a normal reference group of 64 patients. The preoperative renograms were matched with the postoperative outcome. Results: Three characteristic types of symmetrical findings in the kidneys were found: no pathological findings, mildly delayed peak and excretion phase and severely delayed peak and excretion phase. Pathological renograms were observed in 36 of 50 (72%) patients. The mean parametric renogram values in ischemic CM were as follows: Group-A (normal kidney function), mPTT = 142 +/- 26.6 sec, RTC15 = 22.3% +/- 4.6% and RI = 24.7 +/- 11.9; Group B (mild dysfunction), mPTT = 210 +/- 44.0 sec, RTC15 = 42.6% +/- 10.3% and RI = 101.4 +/- 50.5; Group C (severe dysfunction), mPTT = 320 +/- 94.2 sec, RTC15 = 79.6% +/- 15.9% and RI = 347.7 +/- 194.7; and reference patients (normal kidney function), mPTT = 137 +/- 31.1 sec, RTC15 = 22.8% +/- 3.8% and RI = 24.6 +/- 7.9. Postoperative serum creatinine levels were <1.5 mg/dl in all Group A patients, between 1.5 and 2.5 mg/dl in 78% of Group B patients and > 2.5 mg/dl in 75% of Group C patients. Conclusion: Renography revealed abnormal kidney function when structural pathology was excluded. The renographic abnormalities in ischemic CM did not reflect simply the circulatory failure. The numerical grading of renograms allowed patient stratification, suggestive of possible renal insufficiency after cardiac transplantation and immunosuppressive therapy. With further experience, renography may become a useful tool for predicting postoperative outcome in ischemic CM.
引用
收藏
页码:2153 / 2158
页数:6
相关论文
共 50 条
  • [1] Clinical and echocardiographic evolution of patients with arrhythmogenic cardiomyopathy before heart transplantation
    Rimac, Goran
    Poulakos, Nickolas
    Beaulieu-Shearer, Alexander
    Dupuis, Celine
    Beaudoin, Jonathan
    Lemay, Sylvain
    Lalancette, Jean-Simon
    Trahan, Sylvain
    Racine, Hugo-Pierre
    Steinberg, Christian
    Senechal, Mario
    Turgeon, Pierre Yves
    CLINICAL TRANSPLANTATION, 2023, 37 (02)
  • [2] Heart transplantation in pediatric patients with restrictive cardiomyopathy
    Sezgin, Atilla
    Karslioglu, Arif Okay
    Balla, Endri
    Varan, Birgul
    Akovali, Nukhet
    Gedik, Helin Gulen
    Kesimci, Elvin
    Akay, Hakki Tankut
    Ozkan, Murat
    Aslamaci, Sait
    TRANSPLANTATION, 2024, 108 (09) : 706 - 706
  • [3] Outcome of heart transplantation in patients with sarcoid cardiomyopathy
    Zaidi, Asim R.
    Zaidi, Ali
    Vaitkus, Paul T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (07): : 714 - 717
  • [4] Outcome of heart transplantation in patients with amyloid cardiomyopathy
    Kpodonu, J
    Massad, MG
    Caines, A
    Geha, AS
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11): : 1763 - 1765
  • [5] Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation
    Cisneros, Julio Zuniga
    Stehlik, Josef
    Selzman, Craig H.
    Drakos, Stavros G.
    McKellar, Stephen H.
    Wever-Pinzon, Omar
    CIRCULATION-HEART FAILURE, 2018, 11 (03) : e004378
  • [6] Heart transplantation in patients with anthracycline-induced cardiomyopathy
    del-Castillo, Santiago L.
    Decotto, Santiago
    Fleitas, Maria M.
    Marenchino, Ricardo
    Garcia-Rivello, Hernan
    Kohan, Dana
    Pizarro, Rodolfo
    Belziti, Cesar A.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (04): : 417 - 421
  • [7] Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy
    Deng, Yu
    Zhang, Nixiao
    Hua, Wei
    Cheng, Sijing
    Niu, Hongxia
    Chen, Xuhua
    Gu, Min
    Cai, Chi
    Liu, Xi
    Huang, Hao
    Cai, Minsi
    Zhang, Shu
    ESC HEART FAILURE, 2022, 9 (02): : 1269 - 1278
  • [8] Exercise Capacity in Patients after Heart Transplantation: Importance of Cardiac Rehabilitation before Heart Transplantation
    Kumasaka, Reon
    Arakawa, Tetsuo
    Nakanisi, Michio
    Funada, Akira
    Demachi, Jun
    Seguchi, Osamu
    Murata, Yoshihiro
    Yanase, Masanobu
    Nakatani, Takeshi
    Goto, Yoichi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S153 - S154
  • [9] Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy
    Davis, Margot K.
    Lee, Peter H. U.
    Witteles, Ronald M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (05): : 658 - 666
  • [10] HEART-TRANSPLANTATION IN PATIENTS WITH CHAGAS-DISEASE CARDIOMYOPATHY
    STOLF, NAG
    HIGUSHI, L
    BOCCHI, E
    BELLOTTI, G
    AULER, JOC
    NETO, VA
    PILEGGI, F
    JATENE, AD
    JOURNAL OF HEART TRANSPLANTATION, 1987, 6 (05): : 307 - 312